期刊文献+

宫颈癌中血管内皮生长因子、环氧合酶-2的表达及意义 被引量:1

The expression cyclooxygase-2 and its relationship with vascular endothelial growth factor and microvessel density in cervical carcinoma
下载PDF
导出
摘要 目的 探讨环氧合酶 - 2 (COX - 2 )在宫颈癌中的表达 ,及其与血管内皮生长因子 (VEGF)表达和肿瘤微血管密度 (MVD)的关系。方法 应用免疫组化法检测 5 4例宫颈癌中COX - 2、VEGF的表达和MVD值 ,并以 1 0例宫颈CIN和 1 0例正常宫颈上皮为对照组。结果 宫颈癌中COX - 2阳性表达率分别为Ⅰ期5 6 7%、Ⅱ期为 6 6 7%、Ⅲ期 77 8%。VEGF在宫颈癌中阳性表达率分别为Ⅰ期 76 7%、Ⅱ期 80 0 % ,Ⅲ期88 9%。COX - 2在宫颈癌Ⅰ、Ⅱ、Ⅲ期间差异无显著性 (P >0 0 5 )。VEGF宫颈癌Ⅰ、Ⅱ期间差异无显著性 (P>0 0 5 ) ,Ⅰ期与Ⅲ期之间差异有显著性 (P <0 0 5 )。COX - 2、VEGF与MVD的表达呈正相关 ,而与不同的病理分级无明显相关性 (P >0 0 5 )。结论 VEGF、COX - 2、MVD在宫颈癌的发生、发展过程中起着重要作用 ,VEGF、COX - 2、MVD值可作为检测指标 ,为宫颈癌的诊断。 Objective To examine the expression of cyclooxygase-2 (COX-2) in cervical carcinoma,and to reveal its relationship with the microvessel density (MVD) and vascular endothelial growth factor (VEGF).Methods The expressions of COX-2 and VEGF,as well as the MVD,were detected immunohistochemically in 54 patients with cervical cancer.Ten cervical intraepithelial neoplasia (CIN) and 10 normal cervixes served as control group.Results The positive rates of COX-2 were 56 7%,66 7% and 77 8% in cervical cancer stage Ⅰ,Ⅱ and Ⅲ,respectively.The positive rates of VEGF were 76 7%,81 3% and 92% in stage Ⅰ,Ⅱ and Ⅲ,respectively.There was no significant difference of COX-2 expression among the stages ( P> 0 05).Significant difference of VEGF between stage Ⅰ and Ⅲ ( P< 0 05) was observed,yet no difference between stage Ⅰ and Ⅱ ( P> 0 05).The expressions of VEGF and COX-2 were positively related to MVD,while not related to pathological differentiation ( P< 0 05).Conclusions VEGF,COX-2 and MVD play very important roles in the tumorigenesis and the development of cervical carcinoma,so they can be used as indexes of cervical carcinomas for diagnosis,clinical staging and therapy.
出处 《中国妇产科临床杂志》 2004年第3期208-210,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 宫颈癌 血管内皮生长因子 环氧合酶-2 肿瘤微血管密度 免疫组化 检测 Cervical carcinoma cyclooxygase-2 Vascular endothelial growth factor Microvessel density
  • 相关文献

参考文献7

  • 1[1]Ore M.Reduced vascular basement-memberane imunostaining in mucosious tumors of the ovary.Int J Cance,1998,799:139
  • 2[2]Yang SJ,Fang ZJ,Suzuki T,et al.Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): Decreased C/EBP beta in endometriosis in associated with overexpression of aromatase.J Clin Endocrinol Metab,2002,87:2336-2345.
  • 3[3]Silver RM,Edwin SS,Trautman MS,et al.The role ofmolecular pathology of cyclooxygenase -2.J clin Invest,1995,95:725-731.
  • 4[4]Dudios RN,Radhlka A,Reddy BS,et al.Increased cyclooxygenase-2 levels in carcinogen-induced rat clonic tumors.Gastroenterolgy,1996,110:1259-1262.
  • 5[5]Kulkarni S,Rader JS,Zhang F,et al.Cycloxygenase-2 is overexpression in human cervical.Cancer Res,2001,7:429-434.
  • 6[6]Lee JS,Kim HS,Jung JJ,et al.Expression of vascular endothelial growth factor in adenocarcinomas of uterine cervix and its tion to angiogensis and p53 and c-erbB-2 protein expression.Gynecol Oncol,2002,85:469-475.
  • 7[7]Kulkurni S,Rader JS,Zhang F.Cyclooxygenase is overexpressed in human cervical cancer.Clin cancer Res,2001,7:429-434.

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部